↓ Skip to main content

Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants

Overview of attention for article published in Cochrane database of systematic reviews, February 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
15 X users
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
176 Dimensions

Readers on

mendeley
185 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants
Published in
Cochrane database of systematic reviews, February 2015
DOI 10.1002/14651858.cd003481.pub6
Pubmed ID
Authors

Arne Ohlsson, Rajneesh Walia, Sachin S Shah

Abstract

Indomethacin is used as standard therapy to close a patent ductus arteriosus (PDA) but is associated with reduced blood flow to several organs. Ibuprofen, another cyclo-oxygenase inhibitor, may be as effective as indomethacin with fewer adverse effects.

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 185 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
Netherlands 1 <1%
Norway 1 <1%
Ethiopia 1 <1%
South Africa 1 <1%
United States 1 <1%
Unknown 178 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 12%
Student > Postgraduate 21 11%
Student > Bachelor 21 11%
Other 19 10%
Researcher 17 9%
Other 46 25%
Unknown 39 21%
Readers by discipline Count As %
Medicine and Dentistry 97 52%
Nursing and Health Professions 15 8%
Agricultural and Biological Sciences 4 2%
Pharmacology, Toxicology and Pharmaceutical Science 4 2%
Biochemistry, Genetics and Molecular Biology 3 2%
Other 16 9%
Unknown 46 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2015.
All research outputs
#2,988,150
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#5,700
of 13,156 outputs
Outputs of similar age
#35,358
of 269,546 outputs
Outputs of similar age from Cochrane database of systematic reviews
#126
of 286 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,546 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 286 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.